Company Overview - Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing next-generation antibody complement therapeutics for severe autoimmune and inflammatory diseases [3] - The company is based in New York City and Waltham, Massachusetts, and is led by an experienced team of biotech and pharma executives [3] - Dianthus Therapeutics is dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency [3] Upcoming Event - Dianthus Therapeutics will participate in the 43rd Annual J P Morgan Healthcare Conference [1] - CEO Marino Garcia will present a corporate overview on January 15, 2025, at 9:00 a m PST / 12:00 p m EST in San Francisco [1] - A live webcast of the presentation will be available on the company's website under the "News and Events" section in the Investors section [2] Additional Information - More details about Dianthus Therapeutics can be found on their website at www dianthustx com [4] - The company can also be followed on LinkedIn for updates [4]
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference